ArticleHeliyon2024

Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma.

Piman Pocasap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.